Evidence map›Paper›PMID 40033380›Full record

ArticleMolecular cancer2025

Distant origin of glioblastoma recurrence: neural stem cells in the subventricular zone serve as a source of tumor reconstruction after primary resection.

Xue Li, Hyun Jung Kim, Jihwan Yoo, Yeonhee Lee, Chang Hyun Nam, Jonghan Park, Soon-Tae Lee, Tae Min Kim, Seung Hong Choi, Jae-Kyung Won and 10 more

Abstract read
In one paragraph

Article in Molecular cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Xue Li *Department of Radiation Oncology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea.
Hyun Jung Kim *Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea.
Jihwan YooDepartment of Neurosurgery, Brain Tumor Center, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Yeonhee LeeDepartment of Anatomy, Korea University College of Medicine, Seoul, South Korea.
Chang Hyun NamGraduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea.
Jonghan ParkCancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Soon-Tae LeeDepartment of Neurology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea.
Tae Min KimCancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Seung Hong ChoiDepartment of Radiology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea.
Jae-Kyung WonDepartment of Pathology, Seoul National University College of Medicine, Seoul, South Korea.
Sung-Hye ParkDepartment of Pathology, Seoul National University College of Medicine, Seoul, South Korea.
Young Seok JuGraduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea.
Jong Bae ParkDepartment of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang-si, Korea.
Se Hoon KimDepartment of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Jong Hee ChangDepartment of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Hong-Gyun WuDepartment of Radiation Oncology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea.
Chul-Kee ParkDepartment of Neurosurgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea.
Jeong Ho LeeGraduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea. jhlee4246@kaist.ac.kr.
Seok-Gu KangDepartment of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea. seokgu9@gmail.com.
Joo Ho LeeDepartment of Radiation Oncology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea. jooholee@snu.ac.kr.

Funding

Korea Health Industry Development Institute HI23C1573National Research Foundation of Korea 2019R1A3B206661923National Research Foundation of Korea 2021R1A2C1095168National Research Foundation of Korea 2022R1A2B5B03001199
6 · The paper itself

Abstract

Glioblastoma (GBM) is the most aggressive and common type of primary malignant brain cancer in adults. GBM often recurs locally near the resection cavity (RC) following the surgical removal of primary tumors. Recent research has reported that neural stem cells (NSCs) in the subventricular zone (SVZ) harboring cancer-driving mutations serve as the cells of origin for human GBM. However, the pathological role of tumor-initiating NSCs in the SVZ in tumor recurrence remains to be elucidated. Here, we explore the potential contribution of mutation-harboring NSCs in the SVZ to tumor recurrence around the RC following surgical resection. Our hypothesis emerged from performing deep sequencing of longitudinal tissues from 10 patients with GBM, including (i) tumor-free SVZ tissue, (ii) primary tumor tissue, (iii) recurrent tumor tissue, and (iv) blood. As a result of this sequencing, we observed evidence suggesting that recurrent tumors show genetic links to the SVZ in 60% (6/10) of patients, which are distinct from the primary tumors. Using a genome-edited mouse model, we further identified that mutation-harboring NSCs appeared to migrate to the RC through the aberrant growth of oligodendrocyte progenitor cells, potentially contributing to the reconstruction of high-grade malignant gliomas in the RC. This process was associated with the CXCR4/CXCL12 axis, as supported by RNA sequencing data from human recurrent GBM. Taken together, our findings suggest that NSCs in human SVZ tissue may play a role in GBM recurrence, potentially highlighting a novel distant contributor of recurrence.

Indexed as

Brain NeoplasmsGlioblastomaLateral VentriclesNeoplasm Recurrence, LocalNeural Stem CellsAnimalsDisease Models, AnimalFemaleHumansMaleMiceMiddle AgedMutationNeoplastic Stem CellsReceptors, CXCR4Receptors, CXCR4GlioblastomaNeural stem cellsRecurrenceSubventricular zone

Identifiers

PMID40033380
PMCPMC11877783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.